These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19755324)

  • 1. Stent selection in patients on oral anticoagulants: can we prevent restenosis and avoid bleeding?
    Steg PG; Ducrocq G
    EuroIntervention; 2009 Sep; 5(4):405, 407. PubMed ID: 19755324
    [No Abstract]   [Full Text] [Related]  

  • 2. Restenosis, Stent Thrombosis, and Bleeding Complications: Navigating Between Scylla and Charybdis.
    Torrado J; Buckley L; Durán A; Trujillo P; Toldo S; Valle Raleigh J; Abbate A; Biondi-Zoccai G; Guzmán LA
    J Am Coll Cardiol; 2018 Apr; 71(15):1676-1695. PubMed ID: 29650125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
    Dangas GD; Caixeta A; Mehran R; Parise H; Lansky AJ; Cristea E; Brodie BR; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Möeckel M; Stone GW;
    Circulation; 2011 Apr; 123(16):1745-56. PubMed ID: 21482968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary stent strut fracture after drug-eluting stent implantation: a newly recognized complication.
    Celik T; Iyisoy A; Dogru MT; Isik E
    Int J Cardiol; 2009 Feb; 132(1):121-2. PubMed ID: 17692950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates.
    Valgimigli M; Patialiakas A; Thury A; McFadden E; Colangelo S; Campo G; Tebaldi M; Ungi I; Tondi S; Roffi M; Menozzi A; de Cesare N; Garbo R; Meliga E; Testa L; Gabriel HM; Airoldi F; Ferlini M; Liistro F; Dellavalle A; Vranckx P; Briguori C;
    J Am Coll Cardiol; 2015 Mar; 65(8):805-815. PubMed ID: 25720624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety of drug-eluting stents.
    Riede FN; Pfisterer M; Jeger R
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1359-78. PubMed ID: 24138523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Perioperative management of patients with drug-eluting coronary stents presenting for non-cardiac surgery].
    Arai F; Kita T; Sasaki S
    Masui; 2008 Jul; 57(7):879-85. PubMed ID: 18649644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: a patient-level meta-analysis of randomized trials.
    Cassese S; De Luca G; Ribichini F; Cernigliaro C; Sansa M; Versaci F; Proietti I; Stankovic G; Stojkovic S; Fernandez-Pereira C; Tomai F; Vassanelli C; Antoniucci D; Serruys PW; Kastrati A; Rodriguez AE
    Atherosclerosis; 2014 Dec; 237(2):410-7. PubMed ID: 25463066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis.
    Bavry AA; Bhatt DL
    Lancet; 2008 Jun; 371(9630):2134-43. PubMed ID: 18572082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stent thrombosis and drug-eluting stents.
    Takayama T; Hiro T; Hirayama A
    J Cardiol; 2011 Sep; 58(2):92-8. PubMed ID: 21839615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stents: issues of late stent thrombosis.
    Lemesle G; Maluenda G; Collins SD; Waksman R
    Cardiol Clin; 2010 Feb; 28(1):97-105. PubMed ID: 19962052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which patients receiving warfarin can be treated safely with a drug-eluting stent?
    Ryding AD; Banning AP
    Heart; 2008 Mar; 94(3):275-7. PubMed ID: 18276815
    [No Abstract]   [Full Text] [Related]  

  • 13. In-stent restenosis.
    Kim MS; Dean LS
    Cardiovasc Ther; 2011 Jun; 29(3):190-8. PubMed ID: 20406239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications.
    ten Berg JM; Hutten BA; Kelder JC; Verheugt FW; Plokker HW
    Circulation; 2001 Apr; 103(16):2042-7. PubMed ID: 11319192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting stents - what should be improved?
    Steffel J; Eberli FR; Lüscher TF; Tanner FC
    Ann Med; 2008; 40(4):242-52. PubMed ID: 18428018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual antiplatelet therapy in acute coronary syndrome after stent implantation: How short is short and how long is long?
    Tsioufis C
    Hellenic J Cardiol; 2018; 59(6):376-377. PubMed ID: 30682418
    [No Abstract]   [Full Text] [Related]  

  • 17. [Advances in adjunctive pharmacological therapy for percutaneous coronary interventions].
    Benito B; Masotti M; Betriu A
    Rev Esp Cardiol; 2005 Jun; 58(6):729-43. PubMed ID: 15970124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intracoronary gamma brachytherapy significantly lowers the restenosis rate after PTCA and stent implantation].
    Strnad V
    Strahlenther Onkol; 2002 Jan; 178(1):51. PubMed ID: 11977393
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-eluting stents to prevent stent thrombosis and restenosis.
    Im E; Hong MK
    Expert Rev Cardiovasc Ther; 2016; 14(1):87-104. PubMed ID: 26567863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.